CKD

Q&As with ASN Foundation Grant Recipients 2018

The following articles are brief Q&A sessions with American Society of Nephrology (ASN) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.


ASN Pre-Doctoral Fellowship Awardimages_pag_thumb.png

Fatimah Khalaf - ASN Pre-Doctoral Fellowship Award (2018)

Name: Fatimah Khalaf

Institution: University of Toledo

Grant: ASN Pre-Doctoral Fellowship Award (2018)

Project Title: Paraoxonase-1 regulation of renal inflammation in Chronic Kidney Disease
 

How would you sum up your research in one sentence?

Roderick Tan, MD, PhD - Carl W. Gottschalk Research Scholar Grant (2018)

Name: Roderick Tan, MD, PhD

Institution: University of Pittsburgh

Grant: Carl W. Gottschalk Research Scholar Grant (2018)

Project Title: Tubular-to-Glomerular Crosstalk in Kidney Disease
 

How would you sum up your research in one sentence?

Nishank Jain, MBBS - Joseph V. Bonventre Career Development Grant (2018)

Name: Nishank Jain, MBBS

Institution: University of Arkansas for Medical Sciences

Grant: Joseph V. Bonventre Career Development Grant (2018)

Project Title: A Mechanistic Study in Patients with Non-Dialysis Chronic Kidney Disease to Investigate Altered Platelet Response to Antiplatelet Therapy (CKD-Platelet Study)
 

How would you sum up your research in one sentence?

Ke Wang, MD - Joseph A. Carlucci Research Fellowship Award (2018)

Name: Ke Wang, MD

Institution: University of Washington

Grant: Joseph A. Carlucci Research Fellowship Award (2018)

Project Title: Proximal Tubule Secretion: A Complementary Marker to GFR in Kidney Disease
 

How would you sum up your research in one sentence?

The Sixth Annual Kidney Health Initiative Stakeholders Meeting

khi may meeting.PNGThe Kidney Health Initiative (KHI), a public-private partnership between the American Society of Nephrology (ASN) and the U.S. Food and Drug Administration (FDA), advances its mission of facilitating innovation and patient safety in kidney disease through its collaborative partnerships with 90 organizations, working together in the largest collaborative body in the kidney community.

Communities Weekly Rewind: IgG1-lambda mesangial proliferative GN

Query
PGNMID is an uncommon diagnosis, and without any evidence of a circulating paraprotein or cell clonality in the bone marrow, what is the pathophysiology of this lesion and how do we go about treating it?

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

ASN, along with 36 kidney organizations, signed letter to Senate Appropriations for additional kidney research funding at NIH

On Monday, April 23, the American Society of Nephrology and a record-setting coalition of 36 other organizations in the kidney community, authored a letter to the leadership of the House and Senate Appropriations Subcommittees that appropriate funds for the National Institutes of Health (NIH).

Pages